2024-11-13T09:11:09-06:00 2023-12-31 410746749 CLIFTONLARSONALLEN LLP 901 NORTH GLEBE ROAD SUITE 200 ARLINGTON VA 22203 990 2023-01-01 161205104 PEDIATRIC INFECTIOUS DISEASES SOCIETY PEDI 7032990200 4040 WILSON BOULEVARD 300 ARLINGTON VA 22203 BARTON GROH VP, FINANCE & ADMINISTRATION 7032990200 2024-11-12 1 0 ROBERT WILLIAMS P01345960 5712279500 2024-11-12 2023 2024-10-15 13:58:12Z BARTON GROH 4040 WILSON BOULEVARD 300 ARLINGTON VA 22203 1260972 0 X WWW.PIDS.ORG X 1995 AR FREEDOM FROM INFECTIONS FOR ALL CHILDREN. 9 9 0 140 0 0 13338 118178 715691 750578 25155 50441 600 15792 754784 934989 0 20000 0 0 0 0 0 0 0 564240 713253 564240 733253 190544 201736 2331498 2613550 525922 447185 1805576 2166365 TO ENHANCE THE HEALTH OF INFANTS, CHILDREN, AND ADOLESCENTS BY PROMOTING EXCELLENCE IN DIAGNOSIS, MANAGEMENT AND PREVENTION OF INFECTIOUS DISEASES THROUGH CLINICAL CARE, EDUCATION, RESEARCH, AND ADVOCACY. 0 0 MEMBERSHIP SERVICES - PIDS PROVIDES VARIOUS SERVICES FOR THE BENEFIT OF ITS MEMBERS, SUCH AS EDUCATIONAL PROGRAMS AND WRITING LETTERS OF SUPPORT OR OPPOSITION TO LEGISLATION AFFECTING CHILDREN. THEY ALSO COLLABORATE WITH OTHER MEDICAL ORGANIZATIONS AND KEEP MEMBERS INFORMED WITH FREQUENT NEWS AND IMMUNIZATION UPDATES. THEY ALSO PROVIDE FELLOWSHIP RESOURCES AND A DATABASE OF RESEARCH FUNDING SOURCES. PUBLICATIONS - THE JOURNAL OF PEDIATRIC INFECTIOUS DISEASES (JPIDS) IS ISSUED MONTHLY AND IS A PEER-REVIEWED MULTIDISCIPLINARY JOURNAL DIRECTED TOWARDS PHYSICIANS AND OTHER HEALTHCARE PROFESSIONALS WHO MANAGE CHILDREN WITH INFECTIOUS DISEASES. THE JOURNAL IS A HIGH-QUALITY SOURCE OF ORIGINAL RESEARCH ARTICLES, CLINICAL TRIAL REPORTS, GUIDELINES, AND TOPICAL REVIEWS, WITH PARTICULAR ATTENTION TO THE INTERESTS AND NEEDS OF THE GLOBAL PEDIATRIC INFECTIOUS DISEASESCOMMUNITIES. CONFERENCES, MEETINGS AND EDUCATIONAL PROGRAMS - WE PROVIDE NETWORKING OPPORTUNITIES, RESEARCH FORUMS AND EDUCATIONAL/CAREER ADVANCEMENT OPPORTUNITIES FOR PARTICIPANTS & ATTENDEES. THE ANNUAL ST. JUDE/PIDS CONFERENCE FOCUSES ON AREAS RELATED TO INFECTIOUS DISEASES, MICROBIOLOGY, TRANSPLANT ID, IMMUNOCOMPROMISED HOSTS & GLOBAL HEALTH. THE CONFERENCE ALSO HAS A SERIES OF CAREER DEVELOPMENT WORKSHOPS, AND THE OPPORTUNITY FOR ATTENDEES TO PRESENT THEIR ORIGINAL RESEARCH TO COLLEAGUES IN PEDIATRIC INFECTIOUS DISEASES. THE PAS SYMPOSIUM IS ALSO PRESENTED ANNUALLY & SHARES THE LATEST ACADEMIC & RESEARCH IN PEDIATRIC INFECTIOUS DISEASES. PREPID IS A COMPREHENSIVE REVIEW & UPDATE OF PEDIATRIC INFECTIOUS DISEASES FOR GENERAL PEDIATRICIANS & PEDIATRIC INFECTIOUS DISEASE PHYSICIANS PREPARING FOR THE CERTIFYING BOARD EXAM. 0 1 0 1 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 3 0 0 0 0 0 0 1 1 0 0 0 X 9 9 0 1 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 X BARTON GROH IDSA'S VP FINANCE & ADMINISTRATION 7032990200 4040 WILSON BLVD STE 300 ARLINGTON VA 22203 X C BUDDY CREECH PAST PRESIDENT 1.00 1.00 X X 0 0 0 KRISTINA BRYANT MEMBER THRU 10/2023 1.00 1.00 X 0 0 0 WILLIAM STEINBACH PRESIDENT 1.00 1.00 X X 0 0 0 DEBRA PALAZZI PRESIDENT-ELECT 1.00 1.00 X X 0 0 0 MONICA ARDURA MEMBER 1.00 1.00 X 0 0 0 ROBERTA DEBIASI MEMBER 1.00 1.00 X 0 0 0 GULIZ ERDEM MEMBER 1.00 1.00 X 0 0 0 NATASHA HALASA MEMBER THRU 10/2023 1.00 1.00 X 0 0 0 ADAM HERSH MEMBER THRU 10/2023 1.00 1.00 X 0 0 0 MATTHEW BOOTS KRONMAN MEMBER 1.00 1.00 X 0 0 0 ANGELA MYERS MEMBER THRU 10/2023 1.00 1.00 X 0 0 0 ELIJAH PAINTSIL MEMBER 1.00 1.00 X 0 0 0 TANVI SHARMA SECRETARY/TREASURER 1.00 1.00 X X 0 0 0 CHRISTY PHILLIPS MSA EXECUTIVE DIRECTOR 32.50 5.00 X 0 0 0 BARTON GROH VP FINANCE AND ADMINISTRATION 1.00 1.00 X 0 0 0 0 0 0 0 0 0 1 INFECTIOUS DISEASES SOCIETY OF AMERICA 4040 WILSON BLVD SUITE 300 ARLINGTON VA 22203 MANAGEMENT SERVICES 626487 1 118178 118178 IDWEEK 900099 369460 369460 MEMBERSHIP DUES 900099 334546 334546 JOURNALS 900099 46572 46572 750578 37498 37498 338926 325983 12943 12943 12943 OTHER REVENUE 900099 15792 15792 15792 934989 766370 0 50441 X 20000 415646 1193 17382 5385 95639 78142 1104 97232 OTHER PROGRAM EXP 1530 733253 687112 799760 153704 146644 1335286 1539337 155396 127809 2331498 2613550 86231 29975 205045 168070 234646 249140 525922 447185 X 1805576 2166365 1805576 2166365 2331498 2613550 201736 159053 0 X X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 0 0 DUE TO AFFILIATE 249140 249140 1 PIDS FOUNDATION 4040 WILSON BOULEVARD 300 ARLINGTON VA 22203 260609932 501(C)(3) 20000 0 TO SUPPORT REDUCING THE BURDENS OF INFECTIOUS DISEASES 1 PART I, LINE 2: FUNDS ARE SENT ELECTRONICALLY AND GRANTEES ARE REQUIRED TO SUBMIT REPORTS TO SUBSTANTIATE UTILIZATION. 0 0 0 FORM 990, PART VII, SECTION A, LINE 5 PEDIATRIC INFECTIOUS DISEASES SOCIETY (PIDS) HAS ENTERED AN AGREEMENT WITH INFECTIOUS DISEASES SOCIETY OF AMERICA (IDSA), AN UNRELATED NONPROFIT ORGANIZATION EXEMPT UNDER SECTION 501(C)(6) OF THE IRC, TO PROVIDE FACILITIES, MANAGEMENT AND ADMINISTRATIVE SERVICES. UNDER THE TERMS OF THE AGREEMENT, PIDS REIMBURSES IDSA AT COST FOR ITS SHARE OF ALL SALARY AND BENEFITS OF PIDS PROFESSIONAL STAFF PAID BY IDSA AND ALLOCATION OF RENTS AND OFFICE OVERHEAD. THE OFFICERS OF PIDS WHO ARE EMPLOYEES OF IDSA ARE: TERRI CHRISTENE PHILLIPS, EXECUTIVE DIRECTOR AND BARTON GROH, VICE PRESIDENT, FINANCE AND ADMINISTRATION. THE TOTAL MANAGEMENT FEE PAID BY PIDS TO IDSA IN 2023 WAS $626,487. FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE PRESIDENT, SECRETARY-TREASURER, PAST PRESIDENT, AND PRESIDENT-ELECT OF THE SOCIETY, AND SHALL INCLUDE OTHER OFFICERS OF THE SOCIETY AS MAY BE APPOINTED BY THE BOARD OF DIRECTORS. IT SHALL MEET DURING THE INTERVALS BETWEEN THE MEETINGS OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL POSSESS AND MAY EXERCISE ALL THE POWERS AND FUNCTIONS OF THE BOARD OF DIRECTORS IN THE MANAGEMENT AND DIRECTION OF THE AFFAIRS OF THE SOCIETY IN ALL CASES IN WHICH SPECIFIC DIRECTIONS SHALL NOT HAVE BEEN GIVEN BY THE BOARD OF DIRECTORS, EXCEPT THAT THE COMMITTEE MAY NOT: (A) AUTHORIZE DISTRIBUTIONS NOT APPROVED BY THE BOARD OF DIRECTORS; (B) APPROVE OR RECOMMEND TO MEMBERS DISSOLUTION, MERGER OR THE SALE, PLEDGE OR TRANSFER OF ALL OR SUBSTANTIALLY ALL OF THE SOCIETY'S ASSETS; (C) ELECT, APPOINT OR REMOVE BOARD MEMBERS OR FILL VACANCIES ON THE BOARD OF DIRECTORS OR ANY OF ITS COMMITTEES; OR (D) ADOPT, AMEND OR REPEAL THE ARTICLES OF INCORPORATION OR BYLAWS. FORM 990, PART VI, SECTION A, LINE 3 THE SOCIETY HAS CONTRACTED WITH THE INFECTIOUS DISEASES SOCIETY OF AMERICA (IDSA), A 501(C)(6) ORGANIZATION, FOR THE PROVISION OF MANAGEMENT SERVICES. THE EXEMPT PURPOSES OF PIDS AND IDSA ARE CONGRUENT: IDSA'S EXEMPT PURPOSE IS TO IMPROVE THE HEALTH OF INDIVIDUALS, COMMUNITIES, AND SOCIETY BY PROMOTING EXCELLENCE IN PATIENT CARE, EDUCATION, RESEARCH, PUBLIC HEALTH, AND FACILITATE PREVENTION OF INFECTIOUS DISEASES, WHILE THE EXEMPT PURPOSE OF PIDS IS TO ENHANCE THE HEALTH OF INFANTS, CHILDREN, AND ADOLESCENTS BY PROMOTING EXCELLENCE IN DIAGNOSIS, MANAGEMENT AND PREVENTION OF INFECTIOUS DISEASES THROUGH CLINICAL CARE, EDUCATION, RESEARCH, AND ADVOCACY FORM 990, PART VI, SECTION A, LINE 6 THE MEMBERSHIP OF THE SOCIETY CONSISTS OF PHYSICIANS, DOCTORAL-LEVEL SCIENTISTS, AND OTHER PERSONS WHO HAVE TRAINING OR ARE IN THE COURSE OF TRAINING IN INFECTIOUS DISEASES OR ITS RELATED DISCIPLINES. PHYSICIANS, DOCTORAL-LEVEL SCIENTISTS, AND OTHER PERSONS WITHOUT FORMAL INFECTIOUS DISEASES TRAINING ARE ELIGIBLE IF THEY ARE IDENTIFIED WITH THE DISCIPLINE OF PEDIATRIC INFECTIOUS DISEASES OR ITS RELATED DISCIPLINES THROUGH CLINICAL PRACTICE, RESEARCH, TEACHING, ADMINISTRATION, OR ANY COMBINATION OF THESE ACTIVITIES. FORM 990, PART VI, SECTION A, LINE 7A MEMBERS OF THE COUNCIL (GOVERNING BODY) ARE ELECTED BY THE MEMBERS OF THE SOCIETY BY BALLOT PRIOR TO, OR AT, THEIR ANNUAL MEETING, AND THEY ASSUME OFFICE AT THE CONCLUSION OF THE ANNUAL MEETING. PARTICIPATION BY ONE-FIFTH OF THE VOTING MEMBERS CONSTITUTES A QUORUM FOR THE ANNUAL MEETING. FORM 990, PART VI, SECTION A, LINE 7B THE BYLAWS MAY BE ALTERED, AMENDED, OR REPEALED AND NEW BYLAWS, NOT INCONSISTENT WITH ANY PROVISION OF THE CERTIFICATE OF INCORPORATION OF PEDIATRIC INFECTIOUS DISEASES SOCIETY. ANY STATUTE, MAY BE ADOPTED BY THE AFFIRMATIVE VOTE OF AT LEAST TWO-THIRDS OF THE MEMBER VOTES ACTUALLY CAST OR A MAJORITY OF THE TOTAL NUMBER OF VOTES ENTITLED TO BE CAST, WHICHEVER IS LESS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE EXECUTIVE DIRECTOR AND IDSA'S VP OF FINANCE BEFORE IT IS FILED. A COPY OF THE FORM 990 IS THEN PROVIDED TO EACH MEMBER OF THE COUNCIL (GOVERNING BODY). FORM 990, PART VI, SECTION B, LINE 12C A COPY OF THE CONFLICT OF INTEREST POLICY IS PROVIDED ANNUALLY TO EACH MEMBER OF THE GOVERNING BODY AS WELL AS TO ALL OFFICERS; EACH IS REMINDED TO REVIEW THE POLICY AND TO REPORT ANY CONFLICTS OF INTEREST. A DESIGNATED BOARD MEMBER IS TASKED WITH MONITORING COMPLIANCE WITH THE POLICY. WHEN A CONFLICT ARISES, ANY CONFLICTED BOARD MEMBER ABSTAINS FROM VOTING ON THE MATTER. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE DIRECTOR AND VP-FINANCE ARE EMPLOYED BY THE MANAGEMENT COMPANY. PART OF THEIR DUTIES INCLUDE PROVIDING MANAGEMENT SERVICES TO PIDS. THE EXECUTIVE DIRECTOR OF PIDS IS ACTUALLY EMPLOYED BY IDSA AND CONTRACTED OUT TO PIDS AT ACTUAL COSTS; THUS, IDSA'S COMPENSATION PROCESS IS USED IN REGARDS TO ESTABLISHING THE COMPENSATION OF PIDS' EXECUTIVE DIRECTOR ALTHOUGH THE FINAL COMPENSATION DECISION IS MADE BY THE PIDS BOARD OF DIRECTORS USING COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION. ALL NEW EMPLOYEES WILL RECEIVE AN INITIAL PERFORMANCE REVIEW WITHIN THREE TO SIX MONTHS OF THE DATE OF HIRE. THE DATE OF THE INITIAL PERFORMANCE REVIEW WILL BE DETERMINED AT THE THREE MONTH ANNIVERSARY DATE, EVEN IF THE ACTUAL REVIEW OCCURS LATER IN THE THREE TO SIX MONTH PERIOD. AFTER THAT, EMPLOYEE PERFORMANCE WILL BE REVIEWED AT LEAST ONCE A YEAR ON OR ABOUT A FIXED REVIEW DATE. PERFORMANCE EVALUATION IS BASED ON QUALITY/QUANTITY OF WORK, TECHNICAL COMPETENCE, RESPONSIBILITY AND JUDGMENT, INITIATIVE AND ADAPTABILITY, DEPENDABILITY, COOPERATION, ATTENDANCE, PUNCTUALITY, ATTITUDE, AND QUALITY OF PERFORMANCE. ALL OF THESE ARE PRINCIPAL FACTORS IN CONSIDERING SALARY AND ANY COMPENSATION ADJUSTMENTS. THIS PROCESS WAS LAST COMPLETED IN 2023. FORM 990, PART VI, SECTION C, LINE 19 THE BYLAWS OF PIDS ARE POSTED ON THE "ABOUT" SECTION OF ITS WEBSITE. THE OTHER GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE NOT GENERALLY MADE AVAILABLE TO THE GENERAL PUBLIC, BUT IF REQUESTS FOR COPIES OF THESE DOCUMENTS WERE RECEIVED, THE SOCIETY WOULD CONSIDER MAKING THEM AVAILABLE TO THE REQUESTOR. FORM 990, PART IX, LINE 11G MEMBERSHIP SERVICES 43,218. JOURNALS AND PUBLICATIONS 52,421. FORM 990, PART XII, LINE 2C THE AUDIT OVERSIGHT PROCESS HAS REMAINED UNCHANGED FROM THE PRIOR YEAR. PEDIATRIC INFECTIOUS DISEASES SOCIETY EDUCATION AND RESEARCH FOUNDATION 4040 WILSON BLVD ARLINGTON VA 22203 260609932 TO SUPPORT RESESARCH AND EDUCATION ACTIVITIES THAT IMPROVE PATIENT CARE VA 501(C)(3) LINE 7 PEDIATRIC INFECTIOUS DISEASES SOCIETY 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 PEDIATRIC INFECTIOUS DISEASES SOCIETY EDUCATION AND RESEARCH FOUNDATION Q 363318 COST PEDIATRIC INFECTIOUS DISEASES SOCIETY EDUCATION AND RESEARCH FOUNDATION P 335731 COST PEDIATRIC INFECTIOUS DISEASES SOCIETY EDUCATION AND RESEARCH FOUNDATION D 127809 COST